Anesthesiologie medicatie

0
Anesthesiologie medicatie
Anesthesiologie medicatie is an iOS app from Koninklijke Boom uitgevers B.V. in the Education category, currently rated — across few ratings. Initial signal reads as no scraped reviews yet: judgment based on metadata only.
Quality Score is 0: Niche (micro-niche or pre-traction stage). For a Education app, that means micro-niche or pre-traction stage. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Education complexity ×1.20 | +$10K |
How we forecast this revenue
LOW CONFIDENCEBU Investment Matrix
Pre-traction · 31/100INDIE TIERlimited signal- 💰 Revenue: Marginal — $200 - $1250/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: None★ across 0 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: ⚠ last update 379d ago — possibly dormant.
- ⚠️ Risk: Moderate — dormant (379d since update).
💰 Forecast Revenue / mo
MODEL| Paid app ($0.00)METRIC | +$2,800 | |
| Mature app (15y old)METRIC | +$1,500 | |
| Single-language (English only)METRIC | −$400 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVE🆕 What's New · v3.1
Profile & Insights
Identification
- App name
- Anesthesiologie medicatie
- Developer
- Koninklijke Boom uitgevers B.V.
- Bundle ID
- nl.tijdstroom.klinischeanesthesiologie
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 17+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Not found
- Description
- De wereld om ons heen verandert continu. Met nog meer kennis. Vernieuwende standpunten. Bij Boom zorgen we voor een beter begrip voor iedereen. => ontdek ons aanbod.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $86/mo
- Top-grossing rank
- Outside top 100 in US Education
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
- Socials
- Not found
- Not found
- Phone
- Not found
- Contact page
- boom.nl/klantenservice/contact
- About page
- boom.nl/klantenservice/teamviewer
📝 About this app
De inhoud van de applicatie bestaat uit een lijst van veelgebruikte anesthesiologische middelen met overzichtelijk gerangschikte informatie over doseringen, eigenschappen, werkingsmechanismen, indicaties, waarschuwingen en farmacologie van de diverse medicamenten. De app beschikt over een calculatorfunctie en de mogelijkheid aantekeningen te maken per middel.… View full description on the official store →
What Worked™ · Development Pipeline
2 EVENTS TRACKEDMulti-Country Performance
Available in 9 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇺🇸 US | 0★ | 0 | — |
| 🇬🇧 GB | 0★ | 0 | — |
| 🇩🇪 DE | 0★ | 0 | — |
| 🇫🇷 FR | 0★ | 0 | — |
| 🇯🇵 JP | 0★ | 0 | — |
| 🇨🇦 CA | 0★ | 0 | — |
| 🇦🇺 AU | 0★ | 0 | — |
| 🇧🇷 BR | 0★ | 0 | — |
| 🇮🇳 IN | 0★ | 0 | — |
Track this app’s revenue
FREE📝 Description
95
Why low confidence: only 0 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
Anesthesiologie medicatie is a very early-stage iOS app in the education space with weak public traction — only 0 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.




